Loading
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Latest filing published 08 Oct 2026 for Alaunos Therapeutics, Inc., €15k. Read the official filing
Filing timeline
BuySaleJaime Vieser
Insider track record
Disclosed buys
3
Disclosed sells
1
Signal history
Closed purchases
Market purchases
3
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -89.7%Entry US$102.00 · Close at T+365 US$10.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jaime Vieser: trading record in brief
Filings by Jaime Vieser span 2 companies, the busiest being Alaunos Therapeutics, Inc. and Mountain Lake Acquisition Corp. Over a trading history stretching from 4 March 2021 to 6 October 2026, the count stands at 13 filings.
The open-market side counts 3 purchases for €950k alongside 1 sale for €4,215. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 9 share grants.
On 2 out of 3 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
The latest filing, published on 8 October 2026, reports a share grant of €15k in Alaunos Therapeutics, Inc. The latest purchase dates back some time: it was published 671 days ago, on 16 December 2024. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jaime Vieser
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
22,669 shares@ US$0.7444Common StockSEC:0001193125-26-417971:0
8,789 shares@ US$1.920.61% mcap1.7% of flowCommon StockSEC:0001193125-26-318100:0
6,515 shares@ US$2.590.33% mcap1.7% of flowCommon StockSEC:0001193125-26-201557:0
5,839 shares@ US$2.891.7% of flowCommon StockSEC:0001193125-26-014115:0
5,340 shares@ US$3.161.7% of flowCommon StockSEC:0001193125-25-301033:0
3,400 shares0Common StockSEC:0000950170-25-094386:0
17,465 shares0Common StockSEC:0000950170-25-054429:0
2,182 shares@ US$2.010.5% of flowCommon StockSEC:0000950170-25-001257:0
25,000 sharesClass A Ordinary Share, par value $0.0001 per shareSEC:0001213900-24-109470:0
Canonical exit: 16 Mar 2025 (T+90)
1,250,000 shares@ US$0.6592.6% of flowCommon StockSEC:0000899243-22-037274:0
Canonical exit: 27 Feb 2023 (T+90)
40,000 shares0Common StockSEC:0000899243-22-023985:0
100,000 shares@ US$1.91100.0% of flowCommon StockSEC:0001209191-21-059131:0
Canonical exit: 28 Dec 2021 (T+90)
4,167 shares0Common StockSEC:0001209191-21-030745:0
13 of 13 declarations
